Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

FDA committee favors accelerated approval of Ziagen

Nov. 3, 1998

Agenerase filed with European regulatory authorities

Nov. 3, 1998

Liposomal GPI-2A associated with unexpected side effects in early clinical trial

Nov. 2, 1998

Licensing opportunity from NIH: antiretroviral agents with unique mechanism of action

Nov. 2, 1998

HIV integrase inhibitors may impart greater efficacy to combination therapies

Oct. 30, 1998

Addition of Remune increases efficacy of HAART in HIV-positive patients

Oct. 29, 1998

Anti-HIV-1 TBZ analogues synthesized and evaluated by European academic group

Oct. 28, 1998

Hughes Institute develops potent and selective d4T analogue as anti-HIV candidate

Oct. 27, 1998

New synthetic anti-HIV compound resembling NNRTIs in development at Nippon Suisan

Oct. 27, 1998

Anti-HIV drug candidate DMP-851 reviewed in the literature

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...